International Stem Cell Corporation , a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, today announced positive data from the first interim analysis of the ongoing IND-enabling pharmacology/toxicology primate study being conducted under the supervision of Professor D. Eugene Redmond Jr.
http://ift.tt/1hGBm0z
http://ift.tt/1hGBm0z
No comments:
Post a Comment